Merck Compensates Docs For Gardasil For Adult Women When Insurers Do Not
This article was originally published in The Pink Sheet Daily
Executive Summary
Replacement dose program reflects Merck’s strategy to increase use in women ages 19 to 26, who may exceed insurers’ age limit for the cervical cancer vaccine.